Source: Eur Respir J, 49 (6) 1700805; 10.1183/13993003.00805-2017
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Andrew J. Peacock. Measuring the effects of treatment in patients with PAH: should we image the right ventricle?. Eur Respir J, 49 (6) 1700805; 10.1183/13993003.00805-2017

Member's Comments

No comment yet.

Related content which might interest you: Treatment of right heart failure on pulmonary arterial hypertension: is going left a step in the right direction? Source: Eur Respir Rev 2009; 19: 4-6 Year: 2010 MRI derived left atrial volume index predicts treatment response in patients with PAH Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Left and right ventricular function in patients with end-stage idiopathic pulmonary fibrosis. Which ventricle is most affected? Source: Annual Congress 2009 - Lung transplantation: pre- and postoperative problems Year: 2009 Imaging the right ventricle: what can we learn? Source: Annual Congress 2009 - The pulmonologist and the right ventricle Year: 2009 Echocardiographic parameters of right ventricular dysfunction in pulmonary hypertension. Usefulness of speckle tracking longitudinal strain of the right ventricle Source: Annual Congress 2010 - Pulmonary vascular diseases Year: 2010 Case 2: Is it left ventricular dysfunction or PAH? Source: International Congress 2017 – CC6 Is it truly pulmonary arterial hypertension? Year: 2017 Can right ventricle imaging improve risk stratification in pulmonary arterial hypertension? Source: Virtual Congress 2021 – Pulmonary embolism: controversies in management Year: 2021 Late Breaking Abstract - Right heart structural changes, exercise capacity and stress induced right ventricle dysfunction in non- severe COPD patients without pulmonary hypertension at rest. Source: International Congress 2018 – New determinants of cardiovascular morbidity in COPD Year: 2018 The consequence of pulmonary hypertension on the right ventricle: physiological concepts Source: Annual Congress 2011 - The burden of pulmonary hypertension in respiratory disease Year: 2011 Right ventricular mechanical efficiency measured in PAH patients using PET Source: Annual Congress 2009 - Clinical management of pulmonary arterial hypertension Year: 2009 Improvements in the dysfunctional right ventricle with Macitentan treatment in a sugen/hypoxic rat model of pulmonary hypertension Source: Virtual Congress 2020 – Experimental approaches to pulmonary hypertension Year: 2020 REPAIR: long-term effects of macitentan on the right ventricle (RV) in pulmonary arterial hypertension (PAH) Source: Virtual Congress 2020 – Updated assessment and treatment of pulmonary arterial hypertension Year: 2020 Evaluation of pulmonary hypertension by right heart catheterisation: does timing matter? Source: Eur Respir J, 56 (3) 1901892; 10.1183/13993003.01892-2019 Year: 2020 Are we selecting the right inhaler for the right COPD patient? Source: Virtual Congress 2021 – Part I: restarting COPD care in the post-COVID era Year: 2021 Cardiac MRI right atrial area measurement thresholds for risk stratification in patients with PAH Source: Virtual Congress 2020 – Clinical evaluation, biomarkers and risk assessment of pulmonary hypertension Year: 2020 Measuring health in pulmonary hypertension: emphasising the right end-point? Source: Eur Respir J 2014; 43: 960-962 Year: 2014 Macitentan treatment improves the dysfunctional right ventricle in a sugen/hypoxic rat model of pulmonary hypertension Source: International Congress 2019 – Pulmonary hypertension: novelties from the bench Year: 2019 Right ventricular global strain and right ventricular dyssynchrony can predict success to pulmonary vasodilators therapy in PH patients Source: Annual Congress 2012 - Pulmonary circulation: clinical diagnosis, treatment, end-points and animal models Year: 2012